Ramtin Agah, the Chief Medical Officer of $RNXT, bought 12,000 shares of the company on 12-16-2025 for an estimated $10,200. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 1.6%. Following this trade, they now own 778,460 shares of this class of $RNXT stock.
$RNXT Insider Trading Activity
$RNXT insiders have traded $RNXT stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $RNXT stock by insiders over the last 6 months:
- RAMTIN AGAH (Chief Medical Officer) has made 4 purchases buying 44,000 shares for an estimated $37,400 and 0 sales.
- SHAUN BAGAI (Chief Executive Officer) has made 2 purchases buying 10,000 shares for an estimated $9,296 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RNXT Hedge Fund Activity
We have seen 13 institutional investors add shares of $RNXT stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AWM INVESTMENT COMPANY, INC. removed 1,006,435 shares (-53.8%) from their portfolio in Q3 2025, for an estimated $1,278,172
- AIGH CAPITAL MANAGEMENT LLC removed 852,082 shares (-24.6%) from their portfolio in Q3 2025, for an estimated $1,082,144
- ALYESKA INVESTMENT GROUP, L.P. removed 688,577 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $905,478
- STONEPINE CAPITAL MANAGEMENT, LLC removed 278,188 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $365,817
- CITADEL ADVISORS LLC added 121,341 shares (+inf%) to their portfolio in Q3 2025, for an estimated $154,103
- RENAISSANCE TECHNOLOGIES LLC added 61,750 shares (+24.5%) to their portfolio in Q3 2025, for an estimated $78,422
- VANGUARD GROUP INC removed 58,479 shares (-3.5%) from their portfolio in Q3 2025, for an estimated $74,268
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RNXT Analyst Ratings
Wall Street analysts have issued reports on $RNXT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 11/21/2025
To track analyst ratings and price targets for $RNXT, check out Quiver Quantitative's $RNXT forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
